Curative hepatitis C treatment is effective in drug users, trial showsBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4346 (Published 09 August 2016) Cite this as: BMJ 2016;354:i4346
- Susan Mayor
Patients with hepatitis C infection being treated for opioid addiction have high rates of virologic response to oral, once daily treatment with a fixed combination of elbasvir and grazoprevir regardless of ongoing drug use, a randomised trial has shown.1
Injecting drug users are the main group affected by hepatitis C in high income countries, but most trials of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial